Instead, we found that ERK5 silencing significantly impaired breast cancer cell invasion through the Matrigel under fetal bovine serum (FBS)-free condition or in response to EGF treatment, but not following FBS stimulation (Fig. 3C and Supplementary Fig. S2C). This evidence concerns the gene MAPK7 and breast carcinoma.